Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
GEN
19m
Asimov and RevOpsis Therapeutics Ink Licensing Deal for Multispecific-Expressing Cell Line
RevOpsis says it is committed to the rapid discovery and development of novel multispecific therapies utilizing its modular ...
GEN
54m
Abzena Expands Analytical Capabilities to Include GMP Cell-Based Potency Testing
Abzena's goal is to help customers optimize drug development strategies, secure funding, and navigate regulatory pathways more effectively.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
To lead Medicare, Medicaid
Bulls legend dies at 81
Commerce secretary pick
2nd-oldest US resident dies
22 trapped for 2 hours
NYC congestion pricing plan
Hacker accessed Gaetz file?
$4B for poorest countries
WY abortion laws rejected
Super Heavy Starship launch
Jeffries wins reelection
Subway chokehold trial
NBA YoungBoy pleads guilty
Debris falls from roof
Travel guide innovator dies
Updates nuclear doctrine
Victims sue Colorado county
Launches bid to lead DNC
Attorney for accusers sued
Rookie of the Year winners
FEMA faces tough questions
Clemency decision delayed
Hush money case delayed
Microsoft pitches AI 'agents'
5 Brazilian officers arrested
Recommended content reset
Tbilisi protest camp raided
Lakers to honor Pat Riley
Crash ratings get update
Jets fire GM Joe Douglas
Related topics
New York Yankees
Dave Sims
Seattle Mariners
WFAN
Feedback